Back
JPMorgan Nasdaq Equity Premium Income ETF Vs. Revolution Medicines, Inc. Industry Stock Comparison
Sell
43
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
Last Price:
$59.16
Seasonality Move:
1.86%
Buy
71
RVMD
Revolution Medicines, Inc.
Last Price:
$118.94
Seasonality Move:
-1.63%
Sell
43
JPMorgan Nasdaq Equity Premium Income ETF (JEPQ)
is a Sell
Is JPMorgan Nasdaq Equity Premium Income ETF a Buy, Sell or Hold?
-
The current JPMorgan Nasdaq Equity Premium Income ETF [JEPQ] share price is $59.16. The Score for JEPQ is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
JEPQ is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Revolution Medicines, Inc. (RVMD)
is a Buy
Is Revolution Medicines, Inc. a Buy, Sell or Hold?
-
The current Revolution Medicines, Inc. [RVMD] share price is $118.64. The Score for RVMD is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
-
RVMD is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
JEPQ Stock Price Chart
What is JPMorgan Nasdaq Equity Premium Income ETF's stock price today?
-
The JPMorgan Nasdaq Equity Premium Income ETF share price today is $59.16Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JEPQ is experiencing buying pressure, which is a positive indicator for future bullish movement.
RVMD Stock Price Chart
What is Revolution Medicines, Inc.'s stock price today?
-
The Revolution Medicines, Inc. share price today is $118.64Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RVMD is experiencing slight buying pressure.
JEPQ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.2 | Buy |
| Relative Strength Index (14 RSI): | 56.67 | Buy |
| Chaikin Money Flow: | 5174363 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (58.15 - 59.15) | Buy |
| Bollinger Bands (100): | (56.33 - 58.71) | Buy |
RVMD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.63 | Buy |
| Relative Strength Index (14 RSI): | 91.23 | Buy |
| Chaikin Money Flow: | 10348603 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (72.46 - 92.98) | Buy |
| Bollinger Bands (100): | (42.46 - 77.64) | Buy |
JEPQ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 58.81 | Buy |
| 20-day SMA: | 58.64 | Buy |
| 50-day SMA: | 58.37 | Buy |
| 200-day SMA: | 55.07 | Buy |
| 8-day EMA: | 58.84 | Buy |
| 20-day EMA: | 58.66 | Buy |
| 50-day EMA: | 57.64 | Buy |
| 200-day EMA: | 38.82 | Buy |
RVMD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 90.66 | Buy |
| 20-day SMA: | 83.7 | Buy |
| 50-day SMA: | 75.06 | Buy |
| 200-day SMA: | 48.99 | Buy |
| 8-day EMA: | 96.11 | Buy |
| 20-day EMA: | 86.55 | Buy |
| 50-day EMA: | 75.94 | Buy |
| 200-day EMA: | 55.57 | Buy |
JPMorgan Nasdaq Equity Premium Income ETF Earnings Growth & JEPQ Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Revolution Medicines, Inc. Earnings Growth & RVMD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.74 per share, and an increase next year of $0.61 per share.
JPMorgan Nasdaq Equity Premium Income ETF Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Revolution Medicines, Inc. Technical Analysis
| Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||